Aponvie
Payments companies reported to CMS as associated with Aponvie. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aponvie, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aponvie
These are the largest totals companies reported as associated with Aponvie. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Randy Robbins | Plano, TX | Anesthesiology | $280,482.09 |
| Eugene Viscusi | Philadelphia, PA | Anesthesiology | $62,161.29 |
| Andrew Noble | Palm Beach Gardens, FL | Adult Reconstructive Orthopaedic Surgery | $50,079.91 |
| Michael Ashmore | Atlanta, GA | Anesthesiology | $48,724.29 |
| Mark Haffey | Nashville, TN | Nurse Anesthetist, Certified Registered | $42,917.09 |
| Alexander Sah | Fremont, CA | Adult Reconstructive Orthopaedic Surgery | $31,784.50 |
| Ronak Desai | Camden, NJ | Anesthesiology | $29,083.17 |
| Kamel Brakta | Shreveport, LA | Surgery | $27,504.30 |
| Michael Lew | Duarte, CA | Anesthesiology | $24,572.16 |
| Scott Sigman | North Chelmsford, MA | Orthopaedic Surgery | $20,120.06 |
Prescribed Aponvie?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.